Have a feature idea you'd love to see implemented?
Let us know!
CVM Cel Sci Corp
Price (delayed)
$0.6045
Market cap
$37.17M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.58
Enterprise value
$46.55M
CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in the Phase 3 study CEL-SCI treated patients
Highlights
The company's EPS rose by 26% YoY and by 8% QoQ
CVM's net income is up by 14% year-on-year and by 2.8% since the previous quarter
Cel Sci's quick ratio has plunged by 67% from the previous quarter and by 65% YoY
The equity has decreased by 43% YoY and by 41% from the previous quarter
Key stats
What are the main financial stats of CVM
Market
Valuations
Earnings
Shares outstanding
61.49M
Market cap
$37.17M
Enterprise value
$46.55M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.86
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$28.35M
EBITDA
-$24.36M
Free cash flow
-$19.11M
Per share
Balance sheet
Liquidity
EPS
-$0.58
Free cash flow per share
-$0.35
Book value per share
$0.16
Revenue per share
$0
TBVPS
$0.44
Total assets
$24.07M
Total liabilities
$15.6M
Debt
$12.13M
Equity
$8.47M
Working capital
-$1.96M
Debt to equity
1.43
Current ratio
0.64
Quick ratio
0.5
Net debt/EBITDA
-0.38
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-102.7%
Return on equity
-239.3%
Return on invested capital
-94.1%
Return on capital employed
-152.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CVM stock price
How has the Cel Sci stock price performed over time
Intraday
-3.74%
1 week
7.93%
1 month
-32.83%
1 year
-75.63%
YTD
-77.78%
QTD
-42.97%
Financial performance
How have Cel Sci's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$27.65M
Net income
-$29.1M
Gross margin
N/A
Net margin
N/A
Cel Sci's operating income has increased by 16% YoY and by 5% from the previous quarter
CVM's net income is up by 14% year-on-year and by 2.8% since the previous quarter
Growth
What is Cel Sci's growth rate over time
Valuation
What is Cel Sci stock price valuation
P/E
N/A
P/B
3.86
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 26% YoY and by 8% QoQ
The stock's price to book (P/B) is 69% less than its 5-year quarterly average of 12.3 and 47% less than its last 4 quarters average of 7.3
The equity has decreased by 43% YoY and by 41% from the previous quarter
Efficiency
How efficient is Cel Sci business performance
CVM's return on equity has dropped by 66% year-on-year and by 10% since the previous quarter
The return on assets has declined by 26% year-on-year and by 4.3% since the previous quarter
Dividends
What is CVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CVM.
Financial health
How did Cel Sci financials performed over time
The total assets is 54% more than the total liabilities
Cel Sci's quick ratio has plunged by 67% from the previous quarter and by 65% YoY
Cel Sci's current ratio has plunged by 62% from the previous quarter and by 56% YoY
CVM's debt is 43% greater than its equity
The company's debt to equity has surged by 63% QoQ and by 51% YoY
The equity has decreased by 43% YoY and by 41% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.